Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2016-03-22 Report Publication Anno…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage AB (publ) offentliggör idag årsredovisningen och bolagsstyrningsrapporten för 2015 samt finansiella mål för perioden 2016 – 2018
Report Publication Announcement Classification · 99% confidence The document is a press release from Biotage AB dated March 22, 2016. The key sentence is: "Biotage AB (publ) offentliggör idag årsredovisningen och bolagsstyrningsrapporten för 2015 samt finansiella mål för perioden 2016 – 2018" (Biotage AB (publ) today publishes the annual report and the corporate governance report for 2015 as well as financial targets for the period 2016 – 2018). Since the document is short (1681 chars) and its primary function is to announce the publication of the Annual Report (årsredovisningen) and the Corporate Governance Report (bolagsstyrningsrapporten), it fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K or CGR itself, but the announcement thereof.
2016-03-22 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)" and details the date, location, procedures for shareholder participation, proxy rules, and the proposed agenda for the meeting. The agenda items cover the election of the chairman, board members, auditors, approval of financial statements, allocation of profit (dividend proposal), and resolutions on compensation guidelines and authorizations for share issuance/repurchase. These elements are characteristic of materials distributed to shareholders in advance of an Annual General Meeting (AGM). This aligns perfectly with the definition for AGM Information (AGM-R). Although it contains proposals that might appear in other filings (like dividend proposals or compensation guidelines), the context is the formal notice and materials for the AGM itself.
2016-03-22 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Bokslutskommuniké' (Year-end report) for Biotage AB for the period January-December 2015. It contains comprehensive financial statements, including income statements, balance sheet summaries, and detailed management commentary on performance, market trends, and outlook. It is a substantive financial report for a period shorter than a full fiscal year (in the context of the release date) or a year-end summary, fitting the definition of an Interim/Quarterly Report (IR) as it provides actual financial data and analysis rather than just an announcement. FY 2015
2016-02-11 Swedish
Audit Report / Information 2015
Audit Report / Information Classification · 98% confidence The document is explicitly titled "Year-end report January - December 2015" and provides comprehensive financial data for the full year (January - December 2015) as well as the fourth quarter (October – December 2015). It includes detailed income statements, balance sheet items, cash flow analysis, and management commentary on the full year's performance. This structure and content strongly indicate a comprehensive annual financial report. Although it is not explicitly labeled '10-K' (which is the SEC filing equivalent), in the context of general corporate filings, a 'Year-end report' containing full audited/reviewed annual financials aligns best with the definition of an Annual Report (10-K). Since the document is very long (59,257 chars) and contains the full results, it is the report itself, not just an announcement (RPA/RNS). Therefore, the classification is 10-K. FY 2015
2016-02-11 English
Information avseende Biotages årsredovisning för 2014
Earnings Release Classification · 99% confidence The document is a press release dated December 16, 2015, titled "Information avseende Biotages årsredovisning för 2014" (Information regarding Biotage's Annual Report for 2014). It explicitly states that the company is publishing this information via a separate press release because the Stock Exchange (NASDAQ OMX Stockholm AB) requested it to announce a required correction to the 2014 financial figures (specifically goodwill impairment and comparative figures) before the upcoming 2015 year-end report. The text details the nature of the accounting adjustment (reversal of goodwill impairment based on IAS 36/IAS 8) and its impact on 2014 results. Since this is an announcement *about* a correction to previously published financial information (the 2014 Annual Report and 2015 interim reports) and is being released separately as mandated by regulators, it functions as a general regulatory announcement or a specific disclosure related to financial reporting corrections. Given the options, it is not the full Annual Report (10-K), nor is it a standard Earnings Release (ER) or Interim Report (IR). It is a specific disclosure mandated by the exchange regarding prior filings. The closest fit for a mandatory, specific regulatory disclosure that isn't covered by other specific codes (like DIRS, DIV, etc.) is the general 'Regulatory Filings' (RNS), or potentially a specific type of 'Report Publication Announcement' (RPA) if it were announcing the release of a report, but here it is announcing a correction *to* a report. Since it is a mandatory disclosure triggered by regulatory oversight concerning past financial statements, RNS is the most appropriate fallback for this specific, non-standard disclosure. FY 2014
2015-12-16 Swedish
Information regarding Biotage’s Annual Report 2014
Regulatory Filings Classification · 99% confidence The document is titled "Information regarding Biotage's Annual Report 2014" and is a press release dated December 16, 2015. It explicitly states that the Stock Exchange requested Biotage to publish information regarding a required correction (reversal of goodwill impairment) in a *separate press release* because the full Year End Report/Annual Report for 2014 was already issued, and the next one (2015 Annual Report) is due later (February 11, 2016). This document is an announcement about a required correction related to past financial reporting (2014 Annual Report) and is being issued separately from the main reports. Since it is a specific regulatory/exchange-mandated announcement that doesn't fit the definitions for ER, IR, 10-K, or AR, and it is a formal disclosure, it best fits the general 'Regulatory Filings' category (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the *release* of a report. Given the context is a specific, mandated disclosure about correcting prior financial figures following regulatory inquiry, RNS (Regulatory Filings) is the most appropriate general classification for this type of specific, non-standard disclosure.
2015-12-16 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.